Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Concomitant oral typhoid (Vivotif) and cholera (Dukoral) vaccination: immune response evaluation
2014-003474-16Phase 4Completed
- Sponsor
- Helsinki University Hospital
- Start
- Jul 2015
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4 trial of typhoid vaccine, live oral and cholera toxin B subunit in typhoid fever, cholera and Enterotoxigenic Escherichia coli diarrhea (2 arms), sponsored by Helsinki University Hospital. Primary endpoint: Specific IgA-, IgG- and IgM-secreting antibody cells (ELISPOT). Started Jul 2015; status: completed.
02
Drugs
typhoid vaccine, live oralcholera toxin B subunit
03
Conditions
typhoid fevercholeraEnterotoxigenic Escherichia coli diarrhea
Beyond the preview
Go deeper on 2014-003474-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-003474-16.